CLINICAL_TRIALS
trial_result
· 2014-03-03
Clinical Trial Update: Study of FG-4592 in Subjects With Chronic Kidney Disease in China [Phase 2]
Summary
A Phase 2 study of roxadustat (FG-4592) for anemia in chronic kidney disease in China has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyntra Bio | Conditions: Anemia in Chronic Kidney Disease | Phase 2 | Status: COMPLETED